Beneficient Cash Flow Statement
BENF|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Beneficient used $58M in operating cash flow and negative free cash flow of $60M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -23.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$2.7B | -$131.0M | -$58.0M |
| Depreciation & Amortization | $3.8M | $3.6M | $1.1M |
| Operating Cash Flow | -$58.2M | -$95.1M | -$54.0M |
| Capital Expenditures | $1.8M | $2.1M | $3.2M |
| Free Cash Flow | -$60.0M | -$97.2M | -$57.2M |
| FCF Margin | 60.8% | 92.7% | -40.8% |